Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | METAP2 | P50579 | 1/20 | 0.44 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29389480 | 0.89 | CYP1A2 (0.74) | CYP1A2ALDH1A1MAPTKDM4ETSHR | |
| SCHEMBL175754 | 0.89 | CYP1A2 (0.43) | CYP1A2ALDH1A1MAPTKDM4ETSHR | |
| SCHEMBL20454555 | 0.89 | CYP1A2 (0.74) | CYP1A2ALDH1A1MAPTKDM4ETSHR | |
| SCHEMBL29506206 | 0.89 | CYP1A2 (0.74) | CYP1A2ALDH1A1MAPTKDM4ETSHR | |
| SCHEMBL29437799 | 0.85 | ALDH1A1 (0.42) | CYP1A2ALDH1A1MAPTKDM4ETSHR | |
| SCHEMBL44930 | 0.85 | ALDH1A1 (0.42) | CYP1A2ALDH1A1MAPTKDM4ETSHR | |
| SCHEMBL1538065 | 0.83 | GAA (0.43) | CYP1A2ALDH1A1MAPTKDM4ETSHR | |
| SCHEMBL1538062 | 0.83 | GAA (0.43) | CYP1A2ALDH1A1MAPTKDM4ETSHR | |
| SCHEMBL29921916 | 0.83 | ALDH1A1 (0.48) | CYP1A2ALDH1A1MAPTKDM4ETSHR | |
| SCHEMBL11559325 | 0.81 | DGAT1 (0.47) | CYP1A2ALDH1A1MAPTKDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113462278-B | Varnish composition, method for producing polyimide resin, and additive | 东京应化工业株式会社 | 2024-06-07 | — | — | CN | disclosed |
| WO-2023098996-A1 | IMPROVED ELECTRODE MATERIAL FOR PRINTING ORGANIC POLYMER BATTERIES | EVONIK OPERATIONS GMBH (DE) | 2023-06-08 | — | — | WO | disclosed |
| US-8530270-B2 | Methods of preparing semiconductive compositions and devices | EASTMAN KODAK COMPANY (US) | 2013-09-10 | — | — | US | disclosed |
| US-8450726-B2 | Articles containing coatings of amic acid salts | EASTMAN KODAK COMPANY (US) | 2013-05-28 | — | — | US | disclosed |
| US-8431433-B2 | Methods of providing semiconductor layers from amic acid salts | EASTMAN KODAK COMPANY (US) | 2013-04-30 | — | — | US | disclosed |
| EP-2576501-A1 | AROMATIC AMIC ACID SALTS AND COMPOSITIONS | Eastman Kodak Company (US) | 2013-04-10 | — | — | EP | disclosed |
| US-8411489-B2 | Semiconducting devices and methods of preparing | EASTMAN KODAK COMPANY (US) | 2013-04-02 | — | — | US | disclosed |
| US-8404892-B2 | Aromatic amic acid salts and compositions | EASTMAN KODAK COMPANY (US) | 2013-03-26 | — | — | US | disclosed |
| US-8350035-B2 | Fluorinated rylenetetracarboxylic acid derivatives and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2013-01-08 | — | — | US | disclosed |
| US-8314265-B2 | Aromatic amic acids or amic esters and compositions | EASTMAN KODAK COMPANY (US) | 2012-11-20 | — | — | US | disclosed |
| US-20110269967-A1 | AROMATIC AMIC ACIDS OR AMIC ESTERS AND COMPOSITIONS | BANK OF AMERICA, N.A., AS AGENT | 2011-11-03 | — | — | US | disclosed |
| WO-2011137133-A2 | SEMICONDUCTING DEVICES AND METHODS OF PREPARING | EASTMAN KODAK COMPANY (US) | 2011-11-03 | — | — | WO | disclosed |
| WO-2011137137-A1 | SEMICONDUCTING ARTICLES | EASTMAN KODAK COMPANY (US) | 2011-11-03 | — | — | WO | disclosed |
| US-20110180784-A1 | ORGANIC SEMICONDUCTING COMPOSITIONS AND N-TYPE SEMICONDUCTOR DEVICES | BANK OF AMERICA, N.A., AS AGENT | 2011-07-28 | — | — | US | disclosed |
| US-20110183462-A1 | METHOD OF MAKING N-TYPE SEMICONDUCTOR DEVICES | BANK OF AMERICA, N.A., AS AGENT | 2011-07-28 | — | — | US | disclosed |
| WO-2011090953-A1 | ORGANIC SEMICONDUCTING COMPOSITIONS AND N-TYPE SEMICONDUCTOR DEVICES | EASTMAN KODAK COMPANY (US) | 2011-07-28 | — | — | WO | disclosed |
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | US | disclosed |
| US-6706855-B1 | CATIONIC POLY(HEXAMETHYLENEBIGUANIDE) BOUND TO CHROMOPHORIC LABEL | AVECIA LIMITED (GB) | 2004-03-16 | — | — | US | disclosed |
| EP-1213967-B1 | ANTIMICROBIAL POLYMER | AVECIA LTD (GB) | 2004-02-04 | — | — | EP | disclosed |
| WO-1994015441-A1 | ELECTROLUMINESCENT DEVICE COMPRISING A CHROMOPHORIC POLYMERIC COMPOSITION | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 1994-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | FXR2, FXR1, FTO | CYP1A2 2280/4885ALDH1A1 4226/4885MAPT 3001/4885 |
| US-20110269967-A1 | AROMATIC AMIC ACIDS OR AMIC ESTERS AND COMPOSITIONS | DDC, AADAC, MYOC | CYP1A2 155/4885ALDH1A1 745/4885MAPT 1597/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.